Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    ES38 - Optimising the Management of SCLC and Neuroendocrine Tumours

    • 14:30 - 15:30
    • 8/09/2022
    • Location: Strauss 1/2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
    • +

      Session Moderator

      14:30 - 14:31  |  Presenter: Feng-Ming Spring Kong

      • Abstract

      Loading...

    • +

      Session Moderator

      15:17 - 15:30  |  Presenter: Nevena M Secen

      • Abstract

      Loading...

    • +

      ES38.01 - Session Introduction

      14:30 - 14:31  |  Presenter: Feng-Ming Spring Kong

      • Abstract

      Loading...

    • +

      ES38.02 - Session Introduction

      14:31 - 14:32  |  Presenter: Nevena M Secen

      • Abstract

      Loading...

    • +

      ES38.03 - What’s the Best Management for CNS Metastases in the Era of IO?

      14:32 - 14:47  |  Presenter: Inga Grills

      • Abstract

      Loading...

    • +

      ES38.04 - Treatment of Relapsed/Refractory SCLC: Old and New Drugs

      14:47 - 15:02  |  Presenter: Charles M Rudin

      • Abstract

      Loading...

    • +

      ES38.05 - How Should We Treat Pulmonary Large-Cell Neuroendocrine Carcinomas?

      15:02 - 15:17  |  Presenter: Andrea Ardizzoni

      • Abstract

      Loading...

    • +

      ES38.06 - Live Q&A

      15:17 - 15:30

      • Abstract

      Loading...

  • +

    ES39 - Role of Novel Biomarkers and Technologies in Optimal Diagnosis and Disease Management: Focus on Liquid Biopsies And Advanced Tissue Diagnostics

    • 14:30 - 15:30
    • 8/09/2022
    • Location: Lehar 1
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Tumor Biology and Biomarkers
    • +

      Session Moderator

      15:20 - 15:30  |  Presenter: Umberto Malapelle

      • Abstract

      Loading...

    • +

      Session Moderator

      15:20 - 15:30  |  Presenter: Christian Diego Rolfo

      • Abstract

      Loading...

    • +

      ES39.01 - Session Introduction

      14:30 - 14:31  |  Presenter: Umberto Malapelle

      • Abstract

      Loading...

    • +

      ES39.02 - Session Introduction

      14:31 - 14:32  |  Presenter: Christian Diego Rolfo

      • Abstract

      Loading...

    • +

      ES39.03 - Advances and Role of CTCs for Lung Cancer Diagnosis and Treatment (Early and Advanced: NSCLC and SCLC)

      14:32 - 14:44  |  Presenter: Caroline Dive

      • Abstract

      Loading...

    • +

      ES39.04 - Optimal Use of ctDNA Analysis Lung Cancer Diagnosis, Response Assessment and Monitoring 

      14:44 - 14:56  |  Presenter: Christian Diego Rolfo

      • Abstract

      Loading...

    • +

      ES39.05 - Biomarker Analysis of the Tumor Microenvironment and Tumor-Immune Cell Interactions Using High-Plex Spatial and Single-Cell Studies

      14:56 - 15:08  |  Presenter: Junko Tanizaki

      • Abstract

      Loading...

    • +

      ES39.06 - Advanced Tumor-Based and Circulating Diagnositics in Early Stage Disease

      15:08 - 15:20  |  Presenter: Lillian Siu

      • Abstract

      Loading...

    • +

      ES39.07 - Live Q&A

      15:20 - 15:30

      • Abstract

      Loading...

  • +

    MA14 - Palliative and Supportive Care - The Forgotten Trade

    • 14:30 - 15:30
    • 8/09/2022
    • Location: Strauss 3
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Palliative and Supportive Care
    • +

      Session Moderator

      14:47 - 14:57  |  Presenter: Maria Werner-Wasik

      • Abstract

      Loading...

    • +

      Session Moderator

      14:47 - 14:57  |  Presenter: Satoko Kono

      • Abstract

      Loading...

    • +

      MA14.01 - Session Introduction

      14:30 - 14:31  |  Presenter: Maria Werner-Wasik

      • Abstract

      Loading...

    • +

      MA14.02 - Session Introduction

      14:31 - 14:32  |  Presenter: Satoko Kono

      • Abstract

      Loading...

    • +

      MA14.03 - Effect of Mirtazapine on Energy Intake in Patients with Anorexia Associated with NSCLC

      14:32 - 14:37  |  Presenter: Oscar Arrieta

      • Abstract

      Loading...

    • +

      MA14.04 - Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study

      14:37 - 14:42  |  Presenter: Narjust Florez (Duma)

      • Abstract

      Loading...

    • +

      MA14.05 - A Double-blind Phase III Trial of Denosumab Biosimilar QL1206 vs Denosumab in Bone Metastatic Tumor: Lung Cancer Cohort Data

      14:42 - 14:47  |  Presenter: Yan Huang

      • Abstract

      Loading...

    • +

      MA14.06 - Discussant

      14:47 - 14:57  |  Presenter: Karin Dieckmann

      • Abstract

      Loading...

    • +

      MA14.07 - The Use of Medical Cannabis Concomitantly with Immune-Check Point Inhibitors (ICI) in Non Small Cell Lung Cancer (NSCLC): A Sigh of Relief?

      14:57 - 15:02  |  Presenter: Barliz Waissengrin

      • Abstract

      Loading...

    • +

      MA14.08 - Longitudinal Symptoms and Health Utility Scores (HUS) in Patients Receiving PD-1 Inhibitors for Metastatic NSCLC

      15:02 - 15:07  |  Presenter: Christopher Poletes

      • Abstract

      Loading...

    • +

      MA14.09 - Lower Paraspinous Muscle Index at First Thoracentesis is Associated with Poor Survival in Non-Small Cell Lung Cancer

      15:07 - 15:12  |  Presenter: Candice L. Wilshire

      • Abstract

      Loading...

    • +

      MA14.10 - Discussant

      15:12 - 15:22  |  Presenter: Devayani Niyogi

      • Abstract

      Loading...

    • +

      MA14.11 - Live Q&A

      15:22 - 15:30

      • Abstract

      Loading...

  • +

    OA15 - Patient Selection in Advanced NSCLC Immunotherapy

    • 14:30 - 15:30
    • 8/09/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      Session Moderator

      14:32 - 00:00  |  Presenter: Pilar Garrido

      • Abstract

      Loading...

    • +

      Session Moderator

      14:32 - 00:00  |  Presenter: António Araújo

      • Abstract

      Loading...

    • +

      OA15.01 - Session Introduction

      14:30 - 14:31  |  Presenter: Pilar Garrido

      • Abstract

      Loading...

    • +

      OA15.02 - Session Introduction

      14:31 - 14:32  |  Presenter: António Araújo

      • Abstract

      Loading...

    • +

      OA15.03 - Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+ NSCLC: Primary Analysis from JAVELIN Lung 100

      14:32 - 14:42  |  Presenter: Martin Reck

      • Abstract

      Loading...

    • +

      OA15.04 - Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC

      14:42 - 14:52  |  Presenter: Solange Peters

      • Abstract

      Loading...

    • +

      OA15.05 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy

      14:52 - 15:02  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer

      15:02 - 15:12  |  Presenter: Delvys Rodriguez-Abreu

      • Abstract

      Loading...

    • +

      OA15.07 - Discussant

      15:12 - 15:22  |  Presenter: Puey Ling Chia

      • Abstract

      Loading...

    • +

      OA15.08 - Live Q&A

      15:22 - 15:30

      • Abstract

      Loading...

  • +

    PL05 - Closing Plenary 5: Access to Drugs (Live Streamed Session)

    • 15:45 - 16:45
    • 8/09/2022
    • Location: Hall C1
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N/A
    • +

      Session Moderator

      Presenter: Yi-Long Wu

      • Abstract

      Loading...

    • +

      Session Moderator

      Presenter: Clarissa Mathias

      • Abstract

      Loading...

    • +

      PL05.01 - Session Introduction

      Presenter: Yi-Long Wu

      • Abstract

      Loading...

    • +

      PL05.02 - Session Introduction

      Presenter: Clarissa Mathias

      • Abstract

      Loading...

    • +

      PL05.03 - How to Double Lung Cancer Survival within 5 Years

      Presenter: Giorgio Scagliotti

      • Abstract

      Loading...

    • +

      PL05.04 - Access to Drugs

      Presenter: Nir Peled

      • Abstract

      Loading...

    • +

      PL05.05 - Drug Development in the 21st Century

      Presenter: Francesco Pignatti

      • Abstract

      Loading...

    • +

      PL05.06 - Closing Remarks

      • Abstract

      Loading...